Skip to main content

Evidence-Based Supplement Research

Evidence-Based Supplement Research

Taurine and Increased Adverse Event

Doses used in studies

g/day: 0.5–6 (median 3.25, IQR 0.5–6) — 1 study

Time to effect

Median: 5 days · IQR 5 days–5 days · Range 5 days–5 days — Reported in 1 of 1 study

1 of 1 paper

Taurine reduces the risk for metabolic syndrome: a systematic review and meta-analysis of randomized controlled trials.
- 2024-05-16
- Meta-Analysis · n = 1,024
- Nutrition & diabetes 14(1)
- - Chih-Chen Tzang
  - Liang-Yun Chi
  - Long-Huei Lin
  - Ting-Yu Lin
  - Ke-Vin Chang
  - Wei-Ting Wu
  - Levent Özçakar
- PubMed: 38755142
- DOI: 10.1038/s41387-024-00289-z
6 Insights on
- Increased Adverse Event
- High evidence
No significant adverse effects were observed compared to the control group.
Effect
Neutral
Effect size
Small
Significant
No
Dose
0.5 g/day to 6 g/day